PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 186 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2014. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $161,000 | -5.3% | 55,900 | +0.2% | 0.00% | – |
Q4 2021 | $170,000 | -60.7% | 55,800 | -9.6% | 0.00% | – |
Q3 2021 | $433,000 | -23.5% | 61,700 | 0.0% | 0.00% | – |
Q2 2021 | $566,000 | -5.7% | 61,700 | 0.0% | 0.00% | – |
Q1 2021 | $600,000 | -10.0% | 61,700 | -5.1% | 0.00% | – |
Q4 2020 | $667,000 | +1.7% | 65,000 | 0.0% | 0.00% | – |
Q3 2020 | $656,000 | -14.9% | 65,000 | -12.0% | 0.00% | – |
Q2 2020 | $771,000 | +13.5% | 73,900 | -8.2% | 0.00% | – |
Q1 2020 | $679,000 | -3.6% | 80,500 | 0.0% | 0.00% | – |
Q4 2019 | $704,000 | -18.8% | 80,500 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $867,000 | -4.3% | 80,500 | +12.9% | 0.00% | 0.0% |
Q2 2019 | $906,000 | -48.9% | 71,300 | +56.0% | 0.00% | 0.0% |
Q1 2019 | $1,773,000 | +90.6% | 45,700 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $930,000 | -88.2% | 45,700 | -73.3% | 0.00% | -80.0% |
Q3 2018 | $7,856,000 | +208.6% | 171,340 | +298.1% | 0.01% | +150.0% |
Q2 2018 | $2,546,000 | -44.9% | 43,040 | -36.6% | 0.00% | -33.3% |
Q1 2018 | $4,621,000 | -23.1% | 67,900 | +11.7% | 0.00% | -25.0% |
Q4 2017 | $6,007,000 | -23.7% | 60,770 | -7.6% | 0.00% | -33.3% |
Q3 2017 | $7,878,000 | +119.1% | 65,790 | +59.9% | 0.01% | +100.0% |
Q2 2017 | $3,596,000 | +147.0% | 41,140 | +5.1% | 0.00% | +200.0% |
Q1 2017 | $1,456,000 | +21.1% | 39,140 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $1,202,000 | -54.2% | 39,140 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $2,624,000 | +88.1% | 39,140 | -16.4% | 0.00% | +100.0% |
Q2 2016 | $1,395,000 | +224.4% | 46,840 | +219.9% | 0.00% | – |
Q1 2016 | $430,000 | -63.0% | 14,640 | -1.3% | 0.00% | -100.0% |
Q4 2015 | $1,163,000 | -5.4% | 14,840 | -9.0% | 0.00% | 0.0% |
Q3 2015 | $1,229,000 | -97.6% | 16,314 | -96.2% | 0.00% | -97.6% |
Q2 2015 | $50,322,000 | -52.7% | 431,021 | -4.4% | 0.04% | -51.2% |
Q1 2015 | $106,498,000 | +21.4% | 451,053 | -2.7% | 0.09% | +17.8% |
Q4 2014 | $87,739,000 | -6.4% | 463,566 | +18.0% | 0.07% | -7.6% |
Q3 2014 | $93,705,000 | +533.7% | 392,776 | +75.3% | 0.08% | +558.3% |
Q2 2014 | $14,787,000 | -70.7% | 224,047 | -53.8% | 0.01% | -72.7% |
Q1 2014 | $50,517,000 | +35.4% | 485,091 | +34.6% | 0.04% | +33.3% |
Q4 2013 | $37,304,000 | +75.5% | 360,325 | -9.0% | 0.03% | +57.1% |
Q3 2013 | $21,257,000 | +7.3% | 396,142 | -11.3% | 0.02% | 0.0% |
Q2 2013 | $19,816,000 | – | 446,612 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |